BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 3019168)

  • 1. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 3. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring and treatment of anti-D in pregnancy.
    Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
    Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 7. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of rhesus immunization in Australia. The first seven years.
    Davey MG
    Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
    Jedwabny A; Suchocki S; Bobrowska G
    Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rhesus-prophylaxis during interventions in early pregnancy].
    Beck A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):613-8. PubMed ID: 6420996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemolytic disease of the newborn caused by anti-c antibodies. Case report].
    Ornat K; Cyran T; Maszkiewicz W
    Acta Haematol Pol; 1988; 19(1-2):75-6. PubMed ID: 3149114
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z; Stolarz E; Banaszkiewicz A; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract]   [Full Text] [Related]  

  • 15. Economics of anti-rhesus prophylaxis in an African population.
    Verkuyl DA
    Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention with anti-D gamma globulin at the Research Institute of Obstetrics and Gynecology].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1984; 23(6):500-4. PubMed ID: 6099699
    [No Abstract]   [Full Text] [Related]  

  • 17. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
    Maas DH; Schneider J
    Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the recommended minimum dose of anti-D adequate considering the rise in obesity?
    Regan FA; Naftalin J; Springer V; Paterson-Brown S
    Transfus Med; 2008 Aug; 18(4):266-8. PubMed ID: 18783586
    [No Abstract]   [Full Text] [Related]  

  • 19. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.